K083080

Substantially Equivalent

IGX PLEX RHEUMATOID ARTHRITIS (RA) ASSAY AND SQIDWORKS DIAGNOSTICS PLATFORM

Applicant: Sqi Diagnostics Systems
Product code: DHR
Advisory panel: Immunology
Date received: 2008-10-16
Decision date: 2009-10-29
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Toronto, On, CA

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.